Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Takeda to acquire Crick spinout GammaDelta Therapeutics

Takeda to acquire Crick spinout GammaDelta Therapeutics

Takeda today announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy.
28 Oct 2021
United Kingdom
Crick news

To view this News Article please log in or create a profile

Similar stories

Images captured during a demo of the microscope
Crick news

CALM STP collaborates with 5 Crick labs on successful UKRI MRC Capital Grant submission

More...
Welcome to our 2024 summer and sandwich students!

More...

PROFESSOR EDITH HEARD
Appointment of new Director and Chief Executive of the Francis Crick Institute

Message to Crick staff from Chairman John Browne shared on 9th July 2024. More...
Looking back on the 2024 Crick Postdoc Symposium

More...

Darren Warrington leads a tour of the Skylab
SkyLab update: final countdown

We are pleased to announce that construction of the Crick's SkyLab is almost finished! More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


Check out

Community
Mentoring
Careers
News
Groups
Events

Legal

Terms
Privacy
Cookies
About
Contact

This website is powered by
ToucanTech